Omega Healthcare Is Maintained at Overweight by Wells Fargo
Omega Healthcare Invts Analyst Ratings
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Cuts Target Price to $41
RBC Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Cuts Target Price to $39
Wedbush Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $38
BofA Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Omega Healthcare Invts Analyst Ratings
JMP Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
Scotiabank Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Maintains Target Price $39
Mizuho Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Maintains Target Price $45
Berenberg Bank Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Maintains Target Price $45
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Cuts Target Price to $38
Jefferies Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $40
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Announces Target Price $39
Omega Healthcare Raised to Outperform From Market Perform by BMO Capital
Omega Healthcare Price Target Maintained With a $45.00/Share by BMO Capital
Omega Healthcare Invts Analyst Ratings
BMO Capital Upgrades Omega Healthcare Investors Inc(OHI.US) to Buy Rating, Maintains Target Price $45